Anticardiolipin antibodies in scleroderma [4]

Journal of Clinical Rheumatology

Volumn 12, Issue 6, 2006, Pages 324-326

  Enzenauer, Raymond J ^a   Collier, David H ^b   Lopez, Luis R ^c  

^a FITZSIMONS ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BioStar Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCLERODERMA; SEROLOGY; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTICARDIOLIPIN; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE;

EID: 33845496516     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000250295.34519.b9     Document Type: Letter

References (18)

1. Asherson RA, Harris ED Jr. Anticardiolipin antibodies - clinical associations. Postgrad Med J. 1986;62:1081-1087.
2. Alarcon-Segovia D, Cardiel MH, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol. 1989;16:762-767.
3. Siebold JR. Scleroderma. In: Harris ED Jr, Budd RC, Firestein GS, et al, eds. Kelley's Textbook of Rheumatology, 7th ed. Philadelphia: WB Saunders; 2005:1279-1308.
4. Salerni R, Rodman GP, Leon DF, et al. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977;86:394-399.
5. Seibold JR. Anticardiolipin antibodies in systemic sclerosis. Arthritis Rheum. 1986;29:1052-1053.
6. Bamberga P, Asero R, Vismara A, et al. Anticardiolipin antibodies in progressive systemic sclerosis. Clin Exp Rheumatol. 1987;5:387-392.
7. McHugh NJ, Reilly PA, McHugh LA, et al. Pregnancy, the menopause and anticardiolipin antibodies in rheumatoid arthritis and systemic sclerosis. Br J Rheumatol. 1987;26(suppl 2):20.
8. Malia RG, Greaves M, Rowlands LM, et al. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin Exp Rheumatol. 1988;73:456-460.
9. Pope JE, Thompson A. The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol. 2000;27:1450-1452.
10. Schoenroth L, Fritzler M, Lonzetti L, et al. Antibodies to beta 2 glycoprotein I and cardiolipin in SSc. Ann Rheum Dis. 2002;61:183-184.
11. Herrick AL, Oogarah P, Brammah TB, et al. Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis. Ann Rheum Dis. 1994;53:349-354.
12. Ihn H, Sato S, Fujimoto M, et al. Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta2-GPI) in systemic sclerosis. Clin Exp Immunol. 1996;105:475-479.
13. Picillo U, Migliaresi S, Marcialis MR, et al. Clinical setting of patients with systemic sclerosis by serum autoantibodies. Clin Rheumatol. 1997;16:378-383.
14. Picillo U, Migliaresi S, Marcialis MR, et al. Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis. Autoimmunity. 1995;20:1-7.
15. Assous N, Allanore Y, Batteau F, et al. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary hypertension and endothelial injury. Clin Exp Rheumatol. 2005;23:199-204.
16. Hasegawa M, Sato S, Yanaba K, et al. Autoantibodies against phoshatidylserine-prothrombin complex in patients with systemic sclerosis. Ann Rheum Dis. 2004;63:1514.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-590.
18. Manoussakis MN, Tzioufas AG, Silis MP, et al. High prevalence of anti-cardiolipin antibodies in a healthy elderly population. Clin Exp Rheumatol. 1987;69:557-565.